Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1996-01-22
1998-12-08
Loring, Susan A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242341, A61K 3909, A61K 3902
Patent
active
058465472
ABSTRACT:
Novel vaccines for use against .beta.-hemolytic Streptococcus colonization or infection are disclosed. The vaccines contain an immunogenic amount of streptococcal C5a peptidase, or a fragment or mutant thereof. Also disclosed is a method of protecting a susceptible mammal against .beta.-hemolytic Streptococcus colonization or infection by administering such a vaccine.
REFERENCES:
patent: 4454121 (1984-06-01), Beachey et al.
patent: 4695562 (1987-09-01), Beachey et al.
patent: 4772584 (1988-09-01), Cleary et al.
patent: 5124153 (1992-06-01), Beachey et al.
patent: 5162226 (1992-11-01), Beachey et al.
Bronze, M., et al., "Epitopes of group A streptococcal M protein that envoke cross-protective local immune responses", J. Immunol., 148, 888-893.
Courtney, H. S., et al., "Analysis of the role of M24 Protein in group A Spreptococcal adhesion and colonization by use of `omega`-interposon mutagenesis", Infect. Immun., 62, 4868-4873, (1994).
Fischetti, V.A., et al., "Protection against streptoccal pharyngeal colonization with vaccines composed of M protein conserved regions", Plenum Press,, 159-167, (1991).
Fischetti, V.A. et al., "Protection against streptococcal pharyngeal colinization with a vacine: M protein recombinant", Science, 244, 1487, (1989).
Ji, Y. et al., "C5a peptidase alters clearance and trafficking of group A streptococci by infected mice", Infect. Immun., 64,, 503-510, (1996).
Ji, Y., et al., "Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A steptococcus", Infect. Immun., 65, 2080-2087, (1997).
Kapur, V., et al., "Vaccination with steptococcal extracellular cysteine protease (interleukin-1B convertase) protects mice against challenge with heterologous group A streptococci", Microbial. Path., 16, 443-450, (1994).
Medaglini, D., et al., "Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization", Proc. Natl. Acad. Sci. USA, 6868-6872, (1995).
Raeder, R., et al., "Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential", J. Infect. Dis., 173, 888-895, (1996).
Sriskandan, S., et al., "Streptococcal pyrogenic exotoxin A (SPEA) release, distribution, and role in a murine model of fasciitis and mult-organ failure due to Streptococcus pyogenes", J. Infect. Dis, 173, 1399-1407, (1996).
Sriskandan, S., et al., "The role of nitric oxide in experimental murine sepsis due to pyrogenic exetoxin A-producing Streptococcus pyogenes", Infect. Immun., 65, 1767-1762, (1997).
Vugia, D.J., et al., "Invasive group A streptococcal infections in children with varicella in Southern California", Pediatr. Infect. Dis. J., vol. 15, No. 2, 146-150, (1996).
Wessels, M., et al., "Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice", Proc. Natl. Sci. USA, 91, 12238-12242, (1994).
D. Bessen et al., "Influence of Intranasal Immunization with Synthetic Peptides Corresponding to Conserved Epitopes of M Protein on Mucosal Colonization by Group A Streptococci", Infection and Immunity, 56, pp. 2666-2672, (Oct. 1988).
S. Booth et al., "Dapsone Suppresses Integrin-Mediated Neutrophil Adherence Function", The Journal of Investigative Dermatology, 98, pp. 135-140, (Feb. 1992).
M. Boyle et al., "Measurement of Leukocyte Chemotaxis In Vivo", Methods in Enzymology, 162, pp. 101-114, (1988).
M. Bronze et al., "Protective Immunity Evoked by Locally Administered Group A Streptococcal Vaccines in Mice", The Journal of Immunology, 141, pp. 2767-2770, (Oct. 1988).
E. Brummer et al., "Immunological Activation of Polymorphonuclear Neutrophils for Fungal Killing: Studies with Murines Cells and Blastomyces Dermatitidis In Vitro", Journal of Leukocyte Biology, 36, pp. 505-520, (1984).
C. Chen et al., "Complete Nucleotide Sequence of the Streptococcal C5a Peptidase Gene of Streptococcus Pyogenes", The Journal of Biological Chemistry, 265, pp. 3161-3167, (1990).
J. Clark et al., "A New Method for Quantitation of Cell-Mediated Immunity in the Mouse" Journal of the Reticuloendothelial Society, 25, pp. 255-267, (Mar. 1979).
P. Cleary et al., "Similarity Between the Group B and A Streptococcal C5a Peptidase Genes", Infection and Immunity, 60, pp. 4239-4244, (Oct. 1992).
P. Cleary et al., "Streptococcal C5a Peptidase is a Highly Specific Endopeptidase", Infection and Immunity, 60, pp. 5219-5223, (Dec. 1992).
P. Cleary et al., "A Streptococcal Inactivator of Chemotaxis: A new Virulence Factor Specific to Group A Streptococci", Recent Advances in Streptococci and Streptococcal Diseases, pp. 179-180. ( Y. Kimura, S. Kotami and Y Shiokawa (ed.); Reedbooks Ltd.; Berkshire, England; 1984.).
P. Cleary et al., "Virulent Human Strains for Group G Streptococci Express a C5a Peptidase Enzyme Similar to that Produced by Group A Streptococci", Infection and Immunity, 59, pp. 2305-2310, July 1991).
P. Fenderson et al., "Tropomyosin Shares immunologic Epitopes with Group A Streptococcal M Proteins", The Jounal of Immunology, 142, pp. 2475-2481, (Apr. 1989).
V. Fischetti, "Streptococcal M Protein: Molecular Design and Biological Behavior", Clinical Microbiology Reviews, 2, pp. 285-314 , (Jul. 1989).
H. Hill et al., "Group B Streptococci Inhibit the Chemotactic Activity of the Fifth Component of Complement", The Journal of Immunology, 141, pp. 3551-3556, (Nov. 1988).
R. Hope-Simpson, "Streptococcus Pyogenes in the Throat: A Study in a Small Population, 1962-1975", J. Hyg. Camb., 87, pp. 109-129, (1981).
U. Laemmli, "Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4", Nature, 277, pp 680-685, (Aug. 1970).
P. Lee et al., "Quantification and Toxicity of Group A Streptococcal Pryogenic Exotoxins in an Animal Model of Toxic Shock Syndrome-Like Illness", Journal of Clinical Microbiology, 27, pp. 1890-1892, (Aug. 1989).
T. Martin et al., "The Effect of Type-Specific Polysaccharide Capsule on the Clearance of Group B Streptococci from the Lungs of Infant and Adult Rats", The Journal of Infectious Diseases, 165, pp. 306-314, (Feb. 1992).
B. Massell et al., "Rheumatic Fever Following Streptococcal Vaccination", JAMA, 207, pp. 1115-1119, (Feb. 1969).
J. McGhee et al., "New Perspective in Mucosal Immunity with Emphasis on Vaccine Development", Seminars in Hematology, 30 , pp. 3-15, (Oct. 1993).
S. O'Connor et al., "The Human Antibody Response to Streptococcal C5a Peptidase", The Journal of Infectious Diseases, 163, pp. 109-116, (Jan. 1991).
S. O'Connor et al., "In Vivo Streptococcus Pyogenes C5a Pepidase Activity: Analysis Using Transposon-and Nitrosoguanidine-Induced Mutants", The Journal of Infectious Diseases, 156, pp. 495-504, (Sep. 1987).
A. Podbielski et al., "The Group A Streptococcal VirR49 Gene Controls Expression of Four Structural Vir Regulon Genes", Infection and Immunity, 63, pp. 9-20, (Jan. 1995).
T. Springer et al., "Mac-1: A Macrophage Differentiation Antigen Indentified by Monoclonal Antibody", European Journal of Immunology, 9, pp. 301-306, (1979).
D. Stevens, "Invasive Group A Streptococcus Infections", Clinical Infectious Diseases, 14, pp. 2-13, (Jan. 1992).
A. Suvorov et al., "C5a Peptidase Gene from Group B Streptococci", Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci, pp. 230-232. (G. Dunny, P. Cleary and L. McKay (ed.); American for Microbiology; Washington, D.C.; 1991).
D. Wexler et al., "Mechanism of Action of the Group A Streptococcal C5a Inactivator", Proc. Natl. Acad. Sci., 82, pp. 8144-8148, (Dec. 1985).
Berge et al The Journal of Biological Chem 270:9862-9867, 1995.
Loring Susan A.
Regents of the University of Minnesota
LandOfFree
Streptococcal C5a peptidase vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Streptococcal C5a peptidase vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcal C5a peptidase vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174649